Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Jackson

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|April 3, 2003
No evidence that panic attacks are associated with the white coat effect in hypertensionS J C Davies, P R Jackson, L E Ramsay, et al.
Heart (British Cardiac Society)|August 22, 2001
Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health surveyI U Haq, L E Ramsay, E J Wallis, et al.
British Journal of Clinical Pharmacology|March 1, 1985
Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamicsR V Lewis, M S Lennard, P R Jackson, et al.
Veterinary Parasitology|March 1, 1986
Detection and characterization of Leishmania species and strains from mammals and vectors by hybridization and restriction endonuclease digestion of kinetoplast DNAP R Jackson, J M Lawrie, J M Stiteler, et al.
British Journal of Clinical Pharmacology|February 1, 1995
Relation between changes in blood pressure and serum ACE activity after a single dose of enalapril and ACE genotype in healthy subjectsG P Todd, I G Chadwick, K S Higgins, et al.
Lancet (London, England)|August 10, 1996
Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield tableL E Ramsay, I U Haq, P R Jackson, et al.
BMJ (Clinical Research Ed.)|March 11, 2000
Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey populationE J Wallis, L E Ramsay, I Ul Haq, et al.
Heart (British Cardiac Society)|August 24, 1999
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatmentD M Pickin, C J McCabe, L E Ramsay, et al.
British Journal of Clinical Pharmacology|April 1, 1989
Timolol metabolism and debrisoquine oxidation polymorphism: a population studyM S Lennard, R V Lewis, L A Brawn, et al.
The American Journal of Medicine|October 20, 1999
Association of panic disorder and panic attacks with hypertensionS J Davies, P Ghahramani, P R Jackson, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Journal of Clinical Hypertension (Greenwich, Conn.)|April 3, 2003
No evidence that panic attacks are associated with the white coat effect in hypertensionS J C Davies, P R Jackson, L E Ramsay, et al.
Heart (British Cardiac Society)|August 22, 2001
Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health surveyI U Haq, L E Ramsay, E J Wallis, et al.
British Journal of Clinical Pharmacology|March 1, 1985
Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamicsR V Lewis, M S Lennard, P R Jackson, et al.
Veterinary Parasitology|March 1, 1986
Detection and characterization of Leishmania species and strains from mammals and vectors by hybridization and restriction endonuclease digestion of kinetoplast DNAP R Jackson, J M Lawrie, J M Stiteler, et al.
British Journal of Clinical Pharmacology|February 1, 1995
Relation between changes in blood pressure and serum ACE activity after a single dose of enalapril and ACE genotype in healthy subjectsG P Todd, I G Chadwick, K S Higgins, et al.
Lancet (London, England)|August 10, 1996
Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield tableL E Ramsay, I U Haq, P R Jackson, et al.
BMJ (Clinical Research Ed.)|March 11, 2000
Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey populationE J Wallis, L E Ramsay, I Ul Haq, et al.
Heart (British Cardiac Society)|August 24, 1999
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatmentD M Pickin, C J McCabe, L E Ramsay, et al.
British Journal of Clinical Pharmacology|April 1, 1989
Timolol metabolism and debrisoquine oxidation polymorphism: a population studyM S Lennard, R V Lewis, L A Brawn, et al.
The American Journal of Medicine|October 20, 1999
Association of panic disorder and panic attacks with hypertensionS J Davies, P Ghahramani, P R Jackson, et al.
Pageof 14